WaferGen Bio Management Performance Evaluation

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Analysis of WaferGen Bio manpower and management performance can provide insight into WaferGen Bio stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with WaferGen Bio systems future performance. See also Your Current Watchlist.

WaferGen Bio Management Effectiveness

The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on asset. This is way below average.

WaferGen Bio Profit Margins

The company has Profit Margin (PM) of (175.04) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (171.93) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.72.

WaferGen Bio Insider Trading

WaferGen Bio systems Benchmark Summation

The output start index for this execution was zero with a total number of output elements of seventeen. WaferGen Bio systems Price Series Summation is a cross summation of WaferGen Bio price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

WaferGen Bio Stakeholders

Rolland Carlson CEO and President and Director, Ph.D
Ivan Trifunovich Executive Chairman, Ph.D
Michael Henighan CFO, Secretary and Treasurer
Makoto Kaneshiro Independent Director, MBA
Robert Schueren Director
Joel Kanter Lead Independent Director
William McKenzie Director
Raymond Hautamaki Independent Director, Ph.D


WaferGen Bio Top Executives
  Rolland Carlson  CEO
CEO and President and Director
  Ivan Trifunovich  Chairman
Executive Chairman

Tenure Analysis

WaferGen Bio Employment Tenure
WaferGen Bio employes about 55 people. The company is managed by 8 executives with total tenure of roughly 47 years, averanging almost 5.0 years of service per executive having 6.0 employee per reported executive.

Manpower Efficiency

Return on WaferGen Bio Manpower
Revenue Per Employee 168 K
Revenue Per Executive 1.2 M
Net Loss Per Employee 379.1 K
Net Loss Per Executive 2.6 M
Working Capital Per Employee 70.9 K
Working Capital Per Executive 487.6 K

Number of Employees

WaferGen Bio Number of Employees Analysis
WaferGen Bio systems is rated fifth in number of employees category among related companies. The total workforce of Measuring and Control Equipment industry is at this time estimated at about 85,647. WaferGen Bio adds roughly 55.0 in number of employees claiming only tiny portion of all equities under Measuring and Control Equipment industry.
See also Your Current Watchlist. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.